Foghorn Therapeutics (FHTX) Other Non-Current Assets (2019 - 2026)

Foghorn Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $3000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 87.5% year-over-year to $3000.0 in Q1 2026; TTM through Mar 2026 was $3000.0, a 87.5% decrease from a year earlier, with the FY2025 full-year figure at $4000.0, down 99.77% from the prior year.
• Other Non-Current Assets retreated to $3000.0 in Q1 2026 per FHTX's latest filing, from $4000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $2.4 million in Q1 2022 and bottomed at $3000.0 in Q1 2026.
• The 5-year median for Other Non-Current Assets is $1.7 million (2022), against an average of $1.3 million.
• Biggest YoY gain for Other Non-Current Assets was 135.85% in 2025; the steepest drop was 99.77% in 2025.
• Year by year, Other Non-Current Assets stood at $1.7 million in 2022, then sank by 34.72% to $1.1 million in 2023, then jumped by 53.18% to $1.7 million in 2024, then plunged by 99.77% to $4000.0 in 2025, then decreased by 25.0% to $3000.0 in 2026.
• Per Business Quant, the three latest FHTX Other Non-Current Assets figures stand at $3000.0 (Q1 2026), $4000.0 (Q4 2025), and $2.0 million (Q3 2025).